Side-by-side comparison of AI visibility scores, market position, and capabilities
Consumer goods company with $6B revenue; Arm & Hammer, OxiClean, Trojan, and Waterpik portfolio targeting mid-tier value-oriented consumers competing with P&G and Colgate-Palmolive.
Church & Dwight is a consumer packaged goods company producing personal care, household, and specialty products across well-known brands including Arm & Hammer (baking soda-based cleaning and dental products), OxiClean (laundry stain remover), Trojan condoms, Vitafusion gummies vitamins, Waterpik water flosser, Batiste dry shampoo, and Zicam cold remedies. Listed on NYSE (NYSE: CHD) and headquartered in Ewing, New Jersey, Church & Dwight generates approximately $6 billion in annual revenue and has demonstrated consistent organic growth through its "power brand" portfolio management strategy.\n\nChurch & Dwight's brand portfolio spans multiple consumer need categories: Arm & Hammer (baking soda as a platform for toothpaste, cat litter, laundry detergent, and odor eliminator), personal care (Waterpik, Batiste dry shampoo, XTRA laundry), vitamins (Vitafusion and L'il Critters gummy vitamins), sexual health (Trojan, Natalist fertility), and household products (OxiClean, Kaboom). The Arm & Hammer baking soda brand's versatility across multiple product categories creates unique brand leverage.\n\nIn 2025, Church & Dwight has been one of the more consistent performers in consumer staples — the company targets value-oriented consumers in mid-tier price positions (above private label, below premium brands) across its categories. It competes with Procter & Gamble, Colgate-Palmolive, and Henkel for household and personal care market share. The company's 2025 strategy focuses on expanding its international distribution (historically US-focused, with international growth potential for brands like Batiste and Waterpik), growing Vitafusion in the wellness supplement category, and pursuing selective brand acquisitions in premium personal care niches.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.